Your browser doesn't support javascript.
loading
Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection.
Astronomo, Rena D; Santra, Sampa; Ballweber-Fleming, Lamar; Westerberg, Katharine G; Mach, Linh; Hensley-McBain, Tiffany; Sutherland, Laura; Mildenberg, Benjamin; Morton, Georgeanna; Yates, Nicole L; Mize, Gregory J; Pollara, Justin; Hladik, Florian; Ochsenbauer, Christina; Denny, Thomas N; Warrier, Ranjit; Rerks-Ngarm, Supachai; Pitisuttithum, Punnee; Nitayapan, Sorachai; Kaewkungwal, Jaranit; Ferrari, Guido; Shaw, George M; Xia, Shi-Mao; Liao, Hua-Xin; Montefiori, David C; Tomaras, Georgia D; Haynes, Barton F; McElrath, Juliana M.
Afiliación
  • Astronomo RD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Santra S; Center of Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Ballweber-Fleming L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Westerberg KG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Mach L; Center of Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Hensley-McBain T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Sutherland L; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Mildenberg B; Center of Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Morton G; Center of Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Yates NL; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Mize GJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Pollara J; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Hladik F; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Ochsenbauer C; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Denny TN; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Warrier R; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Rerks-Ngarm S; Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand.
  • Pitisuttithum P; Department of Clinical Tropical Medicine, Mahidol University, Bangkok, Thailand.
  • Nitayapan S; Royal Thai Army Component, Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand.
  • Kaewkungwal J; Department of Tropical Hygiene, Mahidol University, Bangkok, Thailand.
  • Ferrari G; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Shaw GM; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Xia SM; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Liao HX; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Montefiori DC; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Tomaras GD; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Haynes BF; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • McElrath JM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA; Department of Laboratory Medicine, University of Washington, Seattle, WA, USA; Department of Global Health, University of Washington,
EBioMedicine ; 14: 97-111, 2016 12.
Article en En | MEDLINE | ID: mdl-27919754

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoglobulina A / Inmunoglobulina G / Anticuerpos Anti-VIH / Infecciones por VIH / VIH-1 / Membrana Mucosa Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: EBioMedicine Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoglobulina A / Inmunoglobulina G / Anticuerpos Anti-VIH / Infecciones por VIH / VIH-1 / Membrana Mucosa Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: EBioMedicine Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos